Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Contract Renewals

7 Feb 2006 07:00

e2v technologies PLC07 February 2006 7 February 2006 e2v secures two contract renewals worth £21m e2v technologies announces it has won two contract renewals worth a total of£21m. Both contracts are for existing OEM customers and are for products within e2v'selectronic tubes product group for use within radiotherapy cancer treatmentsystems. These products generate and deliver the exceptional levels of microwave powerrequired to drive the linear accelerator within radiotherapy systems, whichconvert the microwave power to X-rays used both in the imaging and radiationtreatment of tumours. e2v has been supporting this important application for inexcess of 30 years and works closely with OEM customers to improve theperformance and reliability of their systems. The largest of the contracts, worth £17m, and with delivery over a 3 yearperiod, is to supply Elekta, headquartered in Sweden with manufacturingfacilities in the UK and China. The second contract, worth $7m (£4m), is with TomoTherapy(R) Inc, based inWisconsin, USA. Delivery is scheduled over a 12 month period. Keith Attwood, Chief Executive of e2v said: "The renewal of these two contracts reinforces our position as a strategicsupplier into the radiotherapy equipment market and is entirely consistent withguidance given in our Interim Report and Accounts issued in December 2005." For further information: e2v technologies plc Tel: 01245 493493Keith Attwood/Mike Hannantwww.e2v.com Gavin Anderson & Company Tel: 020 7554 1400Charlotte Stone/Keith Brookbank NOTES FOR EDITORS e2v technologies plc e2v technologies delivers the radio frequency and sensing technology thatenables some of the world's most innovative medical and science, aerospace anddefence, and industrial and commercial systems. For the year ended 31 March2005, e2v achieved sales of £100.5m. It is listed on the London Stock Exchange(e2v.l). e2v is a leading developer and manufacturer of high-technology electroniccomponents and subsystems, which it supplies into three core areas: •Medical & Science : Sensor technology includes Dental X-ray, Mammography, life science applications and X-ray microscopy. Electronic Tubes are the enabling technology behind radiotherapy cancer treatments, microwave medical therapy and high-energy physics. •Aerospace & Defence : Sensor technology includes military surveillance, targeting and guidance; space-based imaging and astronomy and radar & electronic warfare. Electronic tubes provide the enabling technology behind radars, electronic countermeasures (ECM), electronic warfare and satellite communications. •Commercial & Industrial : Sensor technology includes marine radars, industrial safety sensors, automotive radars and alarms and thermal imaging cameras used by fire fighters. Electronic tubes provide enabling technology behind TV broadcast, satellite communications, marine radar and food & industrial processing. e2v has 1,300 employees worldwide with offices in UK, USA, Germany, France,Canada and a presence in China through the China Britain Business Council, aswell as a network of distributors covering other key territories. Further information on e2v technologies plc is available from its website,www.e2v.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Jan 20172:47 pmRNSForm 8.3 - E2V Technologies Plc
23rd Jan 201712:59 pmBUSForm 8.3 - E2V
23rd Jan 201712:33 pmRNSForm 8.3 - E2V Technologies Plc
23rd Jan 201710:16 amRNSForm 8.3 - E2V Technologies
20th Jan 20173:20 pmRNSForm 8.3 - e2v Technologies Plc
20th Jan 201712:29 pmBUSForm 8.3 - E2V TECHNOLOGIES PLC
20th Jan 201710:40 amRNSForm 8.3 - E2V Technologies
20th Jan 20179:28 amRNSForm 8.3 - E2V Technologies Plc
19th Jan 201711:19 amRNSForm 8.3 - E2V Technologies
19th Jan 201710:17 amRNSForm 8.5 (EPT/RI)
18th Jan 20174:55 pmRNSAcquisition Debt Facility Agreement
18th Jan 20173:37 pmRNSHolding(s) in Company
18th Jan 20173:20 pmRNSForm 8.3 - e2v Technologies Plc
18th Jan 201711:20 amBUSForm 8.3 - E2V TECHNOLOGIES
18th Jan 20179:29 amRNSForm 8.3 - E2V Technologies Plc
17th Jan 20174:50 pmRNSRule 2.9 Announcement
17th Jan 20173:20 pmRNSForm 8.3 - e2v Technologies Plc
17th Jan 20172:04 pmRNSForm 8.3 - [e2v Technologies]
17th Jan 201712:12 pmRNSForm 8.3 - E2V Technologies
16th Jan 20173:20 pmRNSForm 8.3 - e2v Technologies Plc
16th Jan 20171:16 pmRNSForm 8.3 - e2v Technologies Plc
16th Jan 201712:26 pmRNSForm 8.3 - E2V Technologies
16th Jan 201711:09 amBUSForm 8.3 - E2V TECHNOLGIES
16th Jan 20179:40 amRNSForm 8.3 - E2V Technologies Plc
16th Jan 20178:40 amRNSForm 8.3 - e2v Technologies plc
13th Jan 20173:20 pmRNSForm 8.3 - e2v Technologies Plc
13th Jan 20173:00 pmBUSForm 8.3 - E2V Technologies Plc
13th Jan 201712:35 pmRNSForm 8.3 - e2v Technologies Plc
13th Jan 201711:59 amRNSForm 8.3 - E2V Technologies
13th Jan 201711:56 amBUSForm 8.3 - E2V TECHNOLOGIES
13th Jan 201711:47 amRNSForm 8.5 (EPT/RI)
12th Jan 20173:20 pmRNSForm 8.3 - e2v Technologies Plc
12th Jan 20173:07 pmRNSForm 8.3 - e2v Technologies plc
12th Jan 20173:00 pmBUSForm 8.3 - E2V Technologies Plc
12th Jan 20172:07 pmBUSForm 8.3 - e2v Technologies Plc
12th Jan 20171:13 pmRNSForm 8.3 - e2v Technologies Plc
12th Jan 201711:52 amBUSForm 8.3 - E2V TECHNOLOGIES
12th Jan 20179:33 amRNSForm 8.3 - e2v Technologies Plc
11th Jan 20172:56 pmRNSForm 8.3 - E2V Technologies Plc
11th Jan 20172:49 pmBUSForm 8.3 - e2v Technologies Plc
11th Jan 201711:31 amBUSForm 8.3 - E2V TECHNOLOGIES
11th Jan 201711:24 amRNSForm 8.3 - E2V PLC
11th Jan 201711:13 amRNSForm 8.3 - E2V Technologies PLC
11th Jan 20179:59 amRNSForm 8.5 (EPT/RI)
11th Jan 20179:27 amRNSForm 8.3 - e2v Technologies Plc
10th Jan 20172:39 pmBUSForm 8.3 - e2v Technologies Plc
10th Jan 201711:55 amBUSForm 8.3 - E2V TECHNOLOGIES
10th Jan 201711:37 amRNSRule 2.9 Announcement
10th Jan 201711:02 amRNSForm 8.3 - E2V Technologies Plc
9th Jan 20171:47 pmBUSForm 8.3 - e2v Technologies Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.